Enzymatic oxidative deamination process

Details for Australian Patent Application No. 2002300926 (hide)

Owner Bristol-Myers Squibb Company

Inventors Swaminathan, Shankar; Lust, David A.; Patel, Ramesh N.; Johnston, Robert M.; Crispino, Gerard; Venit, John J.; Goldberg, Steven L.; Srivastava, Sushil; Moniot, Jerome L.; Winter, William J.; Nanduri, Venkata B.; Anderson, Neal G.; Banerjee, Amit; Szarka, Laszlo J; Tully, Thomas P.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002300926

Parent 57976

Filing date 5 September 2002

Wipo publication date 20 February 2003

Acceptance publication date 18 January 2007

International Classifications

C12P 21/00 (2006.01) Preparation of peptides or proteins

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002300926

18 January 2007 Application Accepted

  Published as AU-B-2002300926

7 June 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002300927-Methods for inhibiting antigen specific T cell responses

2002300925-Ceramic Powder Transfer Process